4/23/2025

Erythromycin Lactobionate Injection

Products Affected - Description

- Erythrocin powder for solution for injection, Pfizer, 500 mg, vial, 10 count, NDC 00409-6482-01

Reason for the Shortage

- Nexus has 500 mg vials available.
- Pfizer has Erythrocin on shortage due to manufacturing delays.

Available Products

- Erythrocin powder for solution for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-6476-44
- Erythromycin Lactobionate powder for solution for injection, Nexus Pharmaceuticals, 500 mg, vial, 10 count, NDC 14789-0116-05

Estimated Resupply Dates

- Pfizer has short-dated Erythrocin 500 mg vials available in limited supply with an expiration date of July 2025. The company estimates a release date of November 2025 for vials with regular dating.

Updated

Updated April 23, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 21, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.